1277419

Avista Pharma Solutions, Inc. dba Cambrex — FEI 3011795391

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 3, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Durham, NC (United States)